JP2015143256A5 - - Google Patents

Download PDF

Info

Publication number
JP2015143256A5
JP2015143256A5 JP2015071166A JP2015071166A JP2015143256A5 JP 2015143256 A5 JP2015143256 A5 JP 2015143256A5 JP 2015071166 A JP2015071166 A JP 2015071166A JP 2015071166 A JP2015071166 A JP 2015071166A JP 2015143256 A5 JP2015143256 A5 JP 2015143256A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
range
layer
ethyl acrylate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2015071166A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015143256A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2015143256A publication Critical patent/JP2015143256A/ja
Publication of JP2015143256A5 publication Critical patent/JP2015143256A5/ja
Pending legal-status Critical Current

Links

JP2015071166A 2008-11-18 2015-03-31 2−オキソ−1−ピロリジン誘導体を含む持続放出製剤 Pending JP2015143256A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP08105817 2008-11-18
EP08105817.4 2008-11-18
EP09100311 2009-06-02
EP09100311.1 2009-06-02

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2011543762A Division JP5954889B2 (ja) 2008-11-18 2009-11-17 2−オキソ−1−ピロリジン誘導体を含む持続放出製剤

Publications (2)

Publication Number Publication Date
JP2015143256A JP2015143256A (ja) 2015-08-06
JP2015143256A5 true JP2015143256A5 (OSRAM) 2016-02-12

Family

ID=41395028

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2011543762A Active JP5954889B2 (ja) 2008-11-18 2009-11-17 2−オキソ−1−ピロリジン誘導体を含む持続放出製剤
JP2015071166A Pending JP2015143256A (ja) 2008-11-18 2015-03-31 2−オキソ−1−ピロリジン誘導体を含む持続放出製剤

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2011543762A Active JP5954889B2 (ja) 2008-11-18 2009-11-17 2−オキソ−1−ピロリジン誘導体を含む持続放出製剤

Country Status (18)

Country Link
US (1) US8460712B2 (OSRAM)
EP (1) EP2358361B1 (OSRAM)
JP (2) JP5954889B2 (OSRAM)
KR (2) KR101788804B1 (OSRAM)
CN (2) CN104083341A (OSRAM)
AU (1) AU2009317279B2 (OSRAM)
BR (1) BRPI0921301A2 (OSRAM)
CA (1) CA2741038C (OSRAM)
DK (1) DK2358361T3 (OSRAM)
EA (1) EA019583B1 (OSRAM)
ES (1) ES2602606T3 (OSRAM)
HK (1) HK1198288A1 (OSRAM)
HU (1) HUE030963T2 (OSRAM)
IL (1) IL212271A (OSRAM)
MX (1) MX356281B (OSRAM)
PL (1) PL2358361T3 (OSRAM)
PT (1) PT2358361T (OSRAM)
WO (1) WO2010057869A1 (OSRAM)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104208714A (zh) * 2008-11-18 2014-12-17 Ucb医药有限公司 含有2-氧代-1-吡咯烷衍生物的延长释放制剂
AU2016381366A1 (en) 2015-12-30 2018-06-28 Adamas Pharmaceuticals, Inc. Methods and compositions for the treatment of seizure-related disorders
WO2017195144A1 (en) * 2016-05-12 2017-11-16 Jubilant Generics Limited Pharmaceutical compositions comprising brivaracetam
EP4337176B1 (en) * 2021-05-11 2025-07-16 Advicenne Prolonged-release pharmaceutical composition for oral administration of sultiame
CN115721624A (zh) * 2021-08-25 2023-03-03 北京海美源医药科技有限公司 一种布立西坦药物组合物及其制备方法和其应用
TR2023017170A1 (tr) * 2023-12-13 2025-06-23 Sanovel İlaç Sanayi̇ Ve Ti̇caret Anoni̇m Şi̇rketi̇ Bri̇varasetam i̇çeren bi̇r saşe formülasyonu

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0004297D0 (en) * 2000-02-23 2000-04-12 Ucb Sa 2-oxo-1 pyrrolidine derivatives process for preparing them and their uses
EA014249B1 (ru) 2005-01-27 2010-10-29 Алембик Лимитед Формуляция леветирацетама длительного высвобождения
WO2006088864A1 (en) * 2005-02-16 2006-08-24 Elan Pharma International Limited Controlled release compositions comprising levetiracetam
US20070298098A1 (en) * 2005-02-16 2007-12-27 Elan Pharma International Limited Controlled Release Compositions Comprising Levetiracetam
US8431156B2 (en) 2005-02-22 2013-04-30 Sun Pharma Advanced Research Company Ltd. Pharmaceutical composition
EP1863453A2 (en) * 2005-03-29 2007-12-12 Evonik Röhm GmbH Multiparticulate pharmaceutical form comprising pellets with a substance having a modular effect in relation to active ingredient release
FR2897267A1 (fr) * 2006-02-16 2007-08-17 Flamel Technologies Sa Formes pharmaceutiques multimicroparticulaires pour administration per os
US8211936B2 (en) * 2006-06-08 2012-07-03 Ucb Pharma, S.A. Co-crystals of pyrrolidinones
MX370905B (es) * 2006-08-31 2020-01-09 Adare Pharmaceuticals Inc Sistema de distribucion de farmacos, que comprenden soluciones solidas de farmacos debilmente basicos.
WO2008062446A2 (en) * 2006-09-14 2008-05-29 Alembic Limited An extended release composition of levetiracetam, which exhibits no adverse food effect
US9555006B2 (en) * 2007-09-21 2017-01-31 Evonik Roehm Gmbh PH-dependent controlled release pharmaceutical composition for non-opioids with resistance against the influence of ethanol
CA2715685C (en) * 2008-03-03 2015-04-28 Eric Schenkel Pharmaceutical solutions, process of preparation and therapeutic uses

Similar Documents

Publication Publication Date Title
JP2015120756A5 (OSRAM)
JP2015143256A5 (OSRAM)
JP2008539802A5 (OSRAM)
HRP20171506T1 (hr) Tableta otporna na mijenjanje koja pruža neposredno oslobađanje lijeka
HRP20191092T1 (hr) Pripravci za oralno doziranje s odgođenim otpuštanjem koji sadrže amorfni cddo-me
RU2015110825A (ru) Устойчивая к действию желудочного сока фармацевтическая или нутрицевтическая композиция со стойкостью к влиянию этанола
KR102229234B1 (ko) 폴리비닐알코올 필름
HRP20171458T1 (hr) Tableta otporna na mijenjanje koja pruža neposredno oslobađanje lijeka
AR017747A1 (es) Perlas farmaceuticas con recubrimiento entcrico, opcionalmente recubiertas con un anti-adherente dispuesto en el exterior de dicho recubrimiento entcrico, y un procedimiento para preparar dichas perlas farmaccuticas con recubrimiento entcrico
RU2015110824A (ru) Фармацевтическая или нутрицевтическая композиция с замедленным высвобождением и стойкостью к воздействию этанола
JP2012515163A5 (OSRAM)
JP2004518750A (ja) 貯蔵安定性を改良するための、医薬品配合物用被覆材料および結合材料
JP2009525300A5 (OSRAM)
JP2009502487A5 (OSRAM)
JP2005514386A5 (OSRAM)
SK106295A3 (en) Thermoplastic for drug covers production, manufacturing process and use thereof
BR112013028453B1 (pt) Uso de uma composição de revestimento, formas de dosagem farmacêuticas ou nutracêuticas gastrorresistentes, e composição do polímero do núcleo/invólucro
JP2010519228A (ja) 作用物質−マトリックス及びポリマー被覆を有しているペレット並びにこのペレットを製造する方法
HRP20150123T1 (hr) Plutajući farmaceutski oblici kontroliranog oslobađanja
JP2006274272A5 (OSRAM)
CN110035744A (zh) 一种尼拉帕尼缓控释药物组合物及其用途
JP2016535030A5 (OSRAM)
JP2020516741A5 (OSRAM)
JP2019513800A5 (OSRAM)
JP2013502993A5 (OSRAM)